Endocrine and Metabolic Diseases Department

Department of Endocrinology, Zhongshan Hospital Affiliated with Xiamen University I. Basic Overview, Qualifications and Honors The Department of Endocrinology of Zhongshan Hospital Affiliated with Xiamen University is renowned in Xiamen and the southwestern Fujian region for its strong technical capabilities and rigorous professional spirit. It is a key medical discipline in Xiamen integrating clinical care, teaching and scientific research. The department has 45 authorized beds, an annual outpatient volume of over 100,000, and over 2,000 inpatient visits; patient satisfaction with hospital-wide blood glucose management is 100%, and the number of clinical experimental projects ranks first in the province. It is the largest insulin pump treatment center in Fujian Province and a national demonstration hospital for “hospital-wide multidisciplinary blood glucose management”. Under the guidance of Professor Yang Xiangjiu, a nationally renowned endocrinologist, the Department of Endocrinology was independently established from the Department of General Internal Medicine in 2004. Through the efforts of department directors Shen Xingping and Chen Xiaomin, it was established as a key medical discipline in Xiamen. It is currently the affiliated institution of the chairperson of endocrinology in Xiamen, and has long led discussions on difficult cases in endocrinology and metabolism, training on new diagnostic and therapeutic developments, and primary healthcare quality control. It is one of the master’s degree training sites for Internal Medicine (Endocrinology) of Xiamen University and Fujian Medical University, as well as a base for standardized physician training and continuing education. As a national drug clinical trial base, it is qualified to undertake Phase I-IV clinical trials of drugs and medical devices. The average length of hospitalization is less than 8 days; its medical reach covers southwestern Fujian, Guangdong, Jiangxi, and overseas regions such as the Philippines and Australia; the department has 30 medical and nursing staff in total, including 12 physicians and a specialized nursing team of 18; it is the largest insulin pump treatment center in Fujian Province and also the largest endocrinology and metabolism drug trial base in Fujian Province. II. Core Diagnostic and Treatment Scope Relying on the hospital’s comprehensive range of clinical specialties, the department has solid medical service capabilities and strong diagnostic and treatment capabilities for difficult and critical illnesses. It routinely provides standardized diagnosis and treatment for various endocrine and metabolic diseases, with particular advantages in the diagnosis and treatment of diabetes, obesity, thyroid diseases, pituitary and adrenal diseases. It can also diagnose and treat rare endocrine diseases such as congenital adrenal hyperplasia and adult growth hormone deficiency, demonstrating the discipline’s profound academic foundation. III. Featured Subspecialties and Core Technical Advantages (1) Featured Subspecialty Layout The department pioneered the “Diabetes and Obesity Reversal Multidisciplinary Clinic”, operates a weight management clinic year-round, and has established subspecialty clinics for intensive diabetes treatment, pituitary-adrenal-gonadal disorders, thyroid eye disease, obesity, diabetic nephropathy and osteoporosis. It has successfully rescued patients with critical illnesses such as thyroid storm, hyperparathyroid crisis and pituitary crisis; diagnosed 21OHD and 11βOHD congenital adrenal hyperplasia, adult growth hormone deficiency, IgG4-related hypophysitis, pseudohypoparathyroidism and other rare diseases; and serves as a regional center for the diagnosis and treatment of rare diseases. (2) Core Specialty Technologies 1. Refined hospital-wide blood glucose management: As the largest insulin pump treatment center in Fujian Province, it provides precise insulin infusion therapy for suitable patients and is responsible for blood glucose management for diabetic patients throughout the hospital. 2. Application of advanced diagnostic and treatment technologies: diabetes and obesity reversal; ablation treatment for refractory hyperthyroidism; preoperative treatment for in vitro fertilization in infertility such as polycystic ovary syndrome; GnRH pulse therapy for premature ovarian failure and IHH; and subspecialty services for pituitary-adrenal-gonadal disorders, thyroid eye disease, obesity, diabetic nephropathy and osteoporosis. It has successfully rescued patients with critical illnesses such as thyroid storm, hyperparathyroid crisis and pituitary crisis. 3. Rare disease diagnosis and treatment capabilities: The department has standardized diagnostic and treatment capabilities for rare endocrine diseases such as congenital adrenal hyperplasia, adult growth hormone deficiency, IgG4-related hypophysitis and pseudohypoparathyroidism. IV. Multidisciplinary MDT Comprehensive Diagnosis and Treatment and Whole-Process Management The department adheres to a diagnostic and treatment model combining multidisciplinary collaboration with integrated Chinese and Western medicine. It operates year-round clinics for diabetes and obesity reversal, a multidisciplinary weight-loss clinic, and a diabetes three-professional co-management clinic, providing whole-process diagnostic and treatment services for patients with diabetes and obesity. Relying on its qualification as a national drug clinical trial base, the department has conducted drug clinical trials for more than ten years and undertaken Phase I-IV clinical trials of original innovative drugs, including GLP-1/GIP/GCG triple agonists, GLP-1 and GIP dual agonists, once-weekly GLP-1 preparations, SGLT2/DPP-IV/MET combination preparations, once-weekly basal insulin preparations, once-weekly growth hormone preparations, once-weekly cabergoline preparations and others, enabling eligible patients to gain early access to the world’s most advanced therapeutic drugs. V. Talent Team and Expert Strength The department currently has 30 medical and nursing staff members, including ４ high-level talents in Xiamen. Its talent echelon has a reasonable structure and covers the full range of clinical diagnosis and treatment and specialized nursing. The physician team includes 4 chief physicians and 7 deputy chief physicians; 100% have postgraduate degrees, including 5 doctoral graduates and 7 master’s graduates, and there are 4 master’s supervisors. Team members have training experience at overseas medical institutions in the United States, Japan and other countries. The specialized nursing team has 18 members, including 4 deputy chief nurses and 6 specialized nurses in health education, who can provide patients with professional specialized nursing and health guidance services. VI. Coordinated Development of Medical Care, Education and Research (1) Medical Services The department has always placed patients’ needs at the center and continuously improved its diagnostic and treatment capabilities for endocrine and metabolic diseases. It has an annual outpatient volume of nearly 100,000 and over 2,000 inpatient visits. It has accumulated rich clinical experience in the diagnosis and treatment of diabetes and its complications, obesity, thyroid diseases, and pituitary and adrenal diseases. Through the hospital-wide multidisciplinary blood glucose management model, standardized application of insulin pumps and implementation of distinctive diagnostic and treatment technologies, it provides high-quality medical services for patients in the region. (2) Teaching and Training As a master’s degree training site for Internal Medicine (Endocrinology) of Xiamen University and Fujian Medical University, the department undertakes the training of master’s students in endocrinology at both institutions. It currently has 4 master’s supervisors and continuously supplies qualified medical professionals in endocrinology to the region. It currently has 3 professors, 1 associate professor, ４ master’s supervisors, and provides teaching to 400 trainees of various types each year; it has cumulatively trained 50 master’s students and enrolls 8 master’s students annually. Each year it holds the provincial and municipal continuing education course—the Zhongshan Endocrinology New Advances Study Course; it currently undertakes more than 10 provincial- and municipal-level scientific research projects and has published nearly a hundred papers over the past ten years, more than 50 of which were published in international SCI-indexed journals; it undertakes the training of master’s students in endocrinology at Xiamen University and Fujian Medical University and is also a base for standardized resident physician training and continuing education. (3) Scientific Research and Innovation The department adheres to innovation-driven discipline development and has reached an advanced domestic level in basic and clinical research on refined hospital-wide blood glucose management, diabetic renal complications, diabetes and obesity reversal treatment, thyroid eye disease and obesity. It currently undertakes more than 10 provincial- and municipal-level scientific research projects and has published nearly 100 papers in academic journals at various levels over the past ten years, more than 50 of them in internationally renowned SCI-indexed journals. It is a national demonstration hospital for “hospital-wide multidisciplinary blood glucose management”; its personnel hold positions 3 person-times in academic organizations at various national levels and 13 person-times in provincial and municipal academic organizations; it has received 3 provincial and municipal science and technology awards; it is renowned in Xiamen and southwestern Fujian for its strong technical capabilities and rigorous professional spirit; research achievements in endocrinology have been published in top international journals. VII. Summary of the Department’s Core Advantages 1. Solid qualifications and platforms: As a key medical discipline in Xiamen, it has core platforms including a master’s degree training site and a national drug clinical trial base. It is a national demonstration hospital for “hospital-wide multidisciplinary blood glucose management”, and the discipline enjoys a strong reputation in Xiamen and southwestern Fujian. 2. Outstanding scale advantage: The department’s core diagnostic and treatment scale data are clear. It is the largest insulin pump treatment center in Fujian Province, serves nearly 100,000 outpatient visits and over 2,000 inpatients annually, and has stable medical service supply capabilities. 3. Distinctive technical features: refined hospital-wide blood glucose management, weight-loss treatment for moderate-to-severe obesity, ablation treatment for refractory hyperthyroidism, preoperative treatment for in vitro fertilization in infertility such as polycystic ovary syndrome, GnRH pulse therapy for premature ovarian failure and IHH; it has successfully rescued patients with critical illnesses such as thyroid storm, hyperparathyroid crisis and pituitary crisis; diagnosed 21OHD and 11βOHD congenital adrenal hyperplasia, adult growth hormone deficiency, IgG4-related hypophysitis, pseudohypoparathyroidism and other rare diseases; and serves as a regional center for the diagnosis and treatment of rare diseases; 4. Innovative service model: It operates a diabetes and obesity reversal multidisciplinary clinic and a diabetes three-professional co-management clinic, supported by a comprehensive out-of-hospital follow-up system. Through clinical trial pathways, it provides patients with opportunities to access advanced treatment options and achieves one-stop diagnostic and treatment services integrating multidisciplinary and Chinese-Western medicine approaches. VIII. Department Vision All colleagues in the Department of Endocrinology will be guided by the Zhongshan spirit of “rigor, pragmatism, diligence and dedication”, adhere to the path of innovative development, continuously strengthen the foundation of discipline development, further develop and expand the discipline of endocrinology and metabolism, continuously improve the quality and technical level of medical services, and provide the general public with higher-quality and more professional diagnostic and treatment services for endocrine and metabolic diseases.